The group will invest almost half a billion euros in a new factory in Neuville-sur-Saone which will allow it to “secure the supply of vaccines”. race for
The group will invest almost half a billion euros in a new factory in Neuville-sur-Saone which will allow it to “secure the supply of vaccines”.
the race for a vaccine is growing. The French laboratory Sanofi will invest 610 million euros in France, especially in the creation of a new location for the production of vaccines, it announced on Tuesday on the occasion of the visit of the president and Emmanuel Macron to one of its factories in Lyon. region.
The group will invest almost half a billion euros in a new factory in Neuville-sur-Saone in the Lyon region, to create its “Evolutive Vaccine Facility”. This new location “will attract the most innovative technologies in the field of vaccine production,” said the laboratory, which added that this 490 million euro investment is expected to create 200 new jobs over five years.
The plant will allow Sanofi to “secure vaccine stocks in France and Europe in case of new pandemics,” the group says, as countries around the world are involved in a race to secure access to a coronavirus vaccine. This new plant will produce 3 to 4 vaccines at a time, compared to one in industrial plants today.
Your support is essential. Subscribe for $1 support us
New center for research and development
“The investment that you are just advertising, this is a great feature of unification between the two acts of the battle that we have to fight,” Emmanuel Macron said on Tuesday during a press conference on the site of Sanofi Marcy-L’etoile, evoking the health crisis receding and the economic crisis that has begun . “The project announced today aims to bring Sanofi and France to excellence in the fight against viruses,” he added.
READ ALSO >> Five questions about the vaccine, AstraZeneca ordered by the European Union
will add to this investment of 120 million euros to create a new research and development center at the Sanofi Pasteur site in Marcy-l’Etoile. This complex will be dedicated to the development of vaccines against emerging diseases and the risk of a pandemic.
Read our full file
“COVID-19”, the new coronavirus
Coronavirus: Disturbing resurgence in Beijing, all schools and universities closed What is dexamethasone, this drug promising against Covid-19? LIVE. In a conversation with the Assembly, Solomon warns of a “second wave”
Sanofi, which is one of the major global vaccine players, is currently working on the development of two vaccines against Covid-19, which are expected in 2021. The group sparked controversy last month, when its CEO Paul Hudson referred to the possibility of encouraging the United States that have invested in the search for vaccines against the coronavirus.
Date of update: June 16, 2020, 12:58 p.m
Categories: Optical Illusion
Source: newstars.edu.vn